retatrutide phase 3 trial results Reta clinical data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in trials Retatrutide Severe Obesity Trial Shows

The study experiment comprised a single session at a controlled "Research Bar" wherein each participant was provided a carefully calculated dose of alcohol designed to achieve a target blood alcohol level

2) The research team of Davies et

What we know Heart muscle coenzyme Q 10 concentration was found to be lower in patients with more severe versus milder heart failure

I think theyre going to become very cheap and widespread in the next five to 10 years. It could be that most people are on a low dose of these, even for cardiovascular protection or other purposes

This can likely be attributed to the action GLP-1 RAs exert on the central nervous system and brain function.15 While effective at reducing caloric intake, we consider it a side effect, as our testing team generally regarded it as an unpleasant experience